In late July, Laboratory Corp. of America Holdings (NYSE: LH) announced the 6th CRO deal to surpass the $1 billion mark this year. The $1.2 billion deal for Chiltern is its third announced transaction this year, having acquired Mount Sinai’s Clinical Outreach Laboratories (January) and Pathology Associates Medical Laboratories, LLC (February).
Pamplona Capital Management was on the hunt for a contract research organization (CRO). After missing out on PPD, the PE firm bagged publicly traded PAREXEL for $5.2 billion.
Private equity firms are taking big stakes in contract research organizations in 2017.
Deals for contract research organizations (CROs) surged 157% in 2016.
Contract research organizations (CROs) are changing hands again, all over the world. Since 2010, we’ve recorded 63 transactions in total, with six announced in 2016 already. That’s a strong showing compared with five CRO deals for all of 2015, but not nearly on pace to surpass the 19 deals posted in 2014. Total combined spending, based on […]